Skip to main content
. 2019 Sep 6;11(9):1317. doi: 10.3390/cancers11091317

Table 3.

Treatment-related adverse events in patients with SCCHN.

TRAEs n (%) Grade 1
n
Grade 2
n
Grade 3
n
Overall 28 (35.9) 8 14 6
Hypothyroidism 5 (6.4) 5
Pneumonia 5 (6.4) 3 1 1
Skin Toxicity 5 (6.4) 1 4
Adrenal Insufficiency 3 (3.8) 3
Colitis/Diarrhea 3 (3.8) 2 1
Stomatitis 2 (2.6) 1 1
Liver Dysfunction 2 (2.6) 1 1
Arthritis 1 (1.3) 1
Diabetes Mellitus 1 (1.3) 1
Renal Dysfunction 1 (1.3) 1

SCCHN, squamous cell carcinoma of the head and neck; TRAEs, treatment-related adverse events.